Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$250.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Strides Arcolab Ltd receives US FDA approval for Methoxsalen softgel capsules


Friday, 6 Jun 2014 12:33am EDT 

Strides Arcolab Ltd:Says that it has received approval from United States & Dru Administration (USFDA) for Methoxsalen capsules USP, 10 mg (Soft gelatin capsules). 

Company Quote

674.0
5.8 +0.87%
22 Jul 2014